Abstract
While insulin delivery technology continues to progress, its adoption in the clinic lags behind, particularly in people with type 2 diabetes. In this article the authors present their clinical perspective regarding insulin pen therapy in this population.
MeSH terms
-
Diabetes Mellitus, Type 1 / drug therapy
-
Diabetes Mellitus, Type 1 / psychology
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Diabetes Mellitus, Type 2 / psychology
-
Equipment Design
-
Humans
-
Hypoglycemic Agents / administration & dosage
-
Hypoglycemic Agents / classification
-
Hypoglycemic Agents / therapeutic use
-
Insulin / administration & dosage
-
Insulin / classification
-
Insulin / therapeutic use*
-
Marketing / methods
-
Needles
-
Perception
Substances
-
Hypoglycemic Agents
-
Insulin